Alex Fässler
Direttore operativo presso Targimmune Therapeutics AG
Patrimonio netto: 3 M $ in data 30/06/2024
Posizioni attive di Alex Fässler
Società | Posizione | Inizio | Fine |
---|---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Direttore operativo | - | - |
Storia della carriera di Alex Fässler
Precedenti posizioni note di Alex Fässler
Società | Posizione | Inizio | Fine |
---|---|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01/01/1998 | - |
BACHEM HOLDING AG | Direttore operativo | 01/01/1998 | - |
Formazione di Alex Fässler
Swiss Federal Institute of Technology | Doctorate Degree |
Statistiche
Distribuzione geografica
Svizzera | 5 |
Posizioni
Chief Operating Officer | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BACHEM HOLDING AG | Health Technology |
Aziende private | 2 |
---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Alex Fässler
- Esperienza